Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $349,382 | 49 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ichnos Sciences Inc. | $267,700 | 44 | $0 (2023) |
| IGI Inc | $79,945 | 3 | $0 (2024) |
| NOVARTIS PHARMACEUTICALS CORPORATION | $1,736 | 2 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $79,945 | 3 | IGI Inc ($79,945) |
| 2023 | $73,008 | 10 | Ichnos Sciences Inc. ($73,008) |
| 2022 | $93,093 | 12 | Ichnos Sciences Inc. ($93,093) |
| 2021 | $101,599 | 22 | Ichnos Sciences Inc. ($101,599) |
| 2019 | $1,736 | 2 | NOVARTIS PHARMACEUTICALS CORPORATION ($1,736) |
All Payment Transactions
49 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 05/24/2024 | IGI Inc | — | — | Cash or cash equivalent | $73,270.60 | Research |
| Study: ISB 1342-101 | ||||||
| 05/24/2024 | IGI Inc | — | — | Cash or cash equivalent | $1,609.00 | Research |
| Study: ISB 1342-101 | ||||||
| 02/23/2024 | IGI Inc | — | — | Cash or cash equivalent | $5,065.83 | Research |
| Study: ISB 1342-101 | ||||||
| 07/31/2023 | Ichnos Sciences Inc. | — | — | Cash or cash equivalent | $19,458.90 | Research |
| Study: ISB 1342-101 | ||||||
| 07/05/2023 | Ichnos Sciences Inc. | — | — | Cash or cash equivalent | $168.01 | Research |
| Study: ISB 1342-101 | ||||||
| 07/03/2023 | Ichnos Sciences Inc. | — | — | Cash or cash equivalent | $252.01 | Research |
| Study: ISB 1342-101 | ||||||
| 06/27/2023 | Ichnos Sciences Inc. | — | — | Cash or cash equivalent | $122.60 | Research |
| Study: ISB 1342-101 | ||||||
| 06/19/2023 | Ichnos Sciences Inc. | — | — | Cash or cash equivalent | $2,580.50 | Research |
| Study: ISB 1342-101 | ||||||
| 05/30/2023 | Ichnos Sciences Inc. | — | — | Cash or cash equivalent | $107.74 | Research |
| Study: ISB 1342-101 | ||||||
| 05/22/2023 | Ichnos Sciences Inc. | — | — | Cash or cash equivalent | $724.77 | Research |
| Study: ISB 1342-101 | ||||||
| 03/30/2023 | Ichnos Sciences Inc. | — | — | Cash or cash equivalent | $47,552.40 | Research |
| Study: ISB 1342-101 | ||||||
| 03/30/2023 | Ichnos Sciences Inc. | — | — | Cash or cash equivalent | $646.00 | Research |
| Study: ISB 1342-101 | ||||||
| 02/06/2023 | Ichnos Sciences Inc. | — | — | Cash or cash equivalent | $1,395.00 | Research |
| Study: ISB 1342-101 | ||||||
| 11/22/2022 | Ichnos Sciences Inc. | — | — | Cash or cash equivalent | $323.00 | Research |
| Study: ISB 1342-101 | ||||||
| 10/13/2022 | Ichnos Sciences Inc. | — | — | Cash or cash equivalent | $775.00 | Research |
| Study: ISB 1342-101 | ||||||
| 08/04/2022 | Ichnos Sciences Inc. | — | — | Cash or cash equivalent | $14,142.27 | Research |
| Study: ISB 1342-101 | ||||||
| 08/04/2022 | Ichnos Sciences Inc. | — | — | Cash or cash equivalent | $2,257.50 | Research |
| Study: ISB 1342-101 | ||||||
| 07/14/2022 | Ichnos Sciences Inc. | — | — | Cash or cash equivalent | $30,076.20 | Research |
| Study: ISB 1342-101 | ||||||
| 07/14/2022 | Ichnos Sciences Inc. | — | — | Cash or cash equivalent | $1,197.00 | Research |
| Study: ISB 1342-101 | ||||||
| 05/09/2022 | Ichnos Sciences Inc. | — | — | Cash or cash equivalent | $19,791.18 | Research |
| Study: ISB 1342-101 | ||||||
| 04/25/2022 | Ichnos Sciences Inc. | — | — | Cash or cash equivalent | $3,151.00 | Research |
| Study: ISB 1342-101 | ||||||
| 02/08/2022 | Ichnos Sciences Inc. | — | — | Cash or cash equivalent | $13,385.70 | Research |
| Study: ISB 1342-101 | ||||||
| 01/27/2022 | Ichnos Sciences Inc. | — | — | Cash or cash equivalent | $1,395.00 | Research |
| Study: ISB 1342-101 | ||||||
| 01/25/2022 | Ichnos Sciences Inc. | — | — | Cash or cash equivalent | $5,324.19 | Research |
| Study: ISB 1342-101 | ||||||
| 01/25/2022 | Ichnos Sciences Inc. | — | — | Cash or cash equivalent | $1,275.00 | Research |
| Study: ISB 1342-101 | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| ISB 1342-101 | Ichnos Sciences Inc. | $267,700 | 44 |
| ISB 1342-101 | IGI Inc | $79,945 | 3 |
| RESEARCH RELATED PUBLICATIONS SUPPORT | NOVARTIS PHARMACEUTICALS CORPORATION | $1,736 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 230 | 421 | $151,185 | $31,378 |
| 2022 | 8 | 310 | 606 | $190,398 | $45,356 |
| 2021 | 9 | 315 | 672 | $196,884 | $47,980 |
| 2020 | 8 | 270 | 563 | $157,001 | $37,500 |
All Medicare Procedures & Services
33 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 47 | 77 | $33,033 | $8,090 | 24.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 61 | 101 | $32,118 | $7,178 | 22.3% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 30 | 121 | $36,663 | $7,108 | 19.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 15 | 37 | $16,132 | $3,263 | 20.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 28 | 34 | $7,208 | $1,648 | 22.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 12 | 12 | $10,116 | $1,519 | 15.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 22 | 24 | $7,320 | $1,287 | 17.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 15 | 15 | $8,595 | $1,285 | 14.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 73 | 137 | $58,773 | $14,112 | 24.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 86 | 184 | $58,512 | $12,257 | 20.9% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 29 | 97 | $26,772 | $7,478 | 27.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 24 | 61 | $11,247 | $3,147 | 28.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 46 | 71 | $15,052 | $3,145 | 20.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2022 | 14 | 14 | $8,652 | $1,917 | 22.2% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 12 | 13 | $6,136 | $1,888 | 30.8% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2022 | 26 | 29 | $5,254 | $1,413 | 26.9% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 42 | 165 | $45,540 | $12,067 | 26.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Facility | 2021 | 72 | 163 | $51,834 | $10,662 | 20.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 50 | 100 | $42,900 | $10,342 | 24.1% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 28 | 85 | $14,365 | $4,190 | 29.2% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 45 | 76 | $16,112 | $3,416 | 21.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 16 | 16 | $7,552 | $2,342 | 31.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2021 | 33 | 38 | $6,536 | $1,931 | 29.5% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Facility | 2021 | 16 | 16 | $7,872 | $1,677 | 21.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 13 | 13 | $4,173 | $1,353 | 32.4% |
About Dr. Sanjay Mohan, MD
Dr. Sanjay Mohan, MD is a Internal Medicine healthcare provider based in Nashville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/30/2008. The National Provider Identifier (NPI) number assigned to this provider is 1215193255.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sanjay Mohan, MD has received a total of $349,382 in payments from pharmaceutical and medical device companies, with $79,945 received in 2024. These payments were reported across 49 transactions from 3 companies. The most common payment nature is "" ($349,382).
As a Medicare-enrolled provider, Mohan has provided services to 1,125 Medicare beneficiaries, totaling 2,262 services with total Medicare billing of $162,215. Data is available for 4 years (2020–2023), covering 33 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Other Specialties Hematology & Oncology
- Location Nashville, TN
- Active Since 07/30/2008
- Last Updated 12/17/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1215193255
Products in Payments
- RYDAPT (Drug) $1,736
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Nashville
Mr. John Anderson, Md, MD
Internal Medicine — Payments: $2.1M
Sandeep Rajan, M.d, M.D
Internal Medicine — Payments: $709,151
Dr. Christopher Ellis, M.d, M.D
Internal Medicine — Payments: $618,290
Dr. Brian Jefferson, Md, MD
Internal Medicine — Payments: $514,499
Dr. Robert Ramirez, D.o, D.O
Internal Medicine — Payments: $467,030
Dr. Michael Morse, M.d, M.D
Internal Medicine — Payments: $444,237